Evangelos Kalaitzakis1, Ervin Toth. 1. Endoscopy Unit, Department of Gastroenterology, Skåne University Hospital, University of Lund, Malmö, Sweden, evangelos.kalaitzakis@medicine.gu.se.
Abstract
BACKGROUND: Population-based data on hospital procedure volume and outcome of endoscopic retrograde cholangiopancreatography (ERCP) are limited. AIMS: To investigate procedural failure, early re-admission, and all-cause mortality following ERCP performed due to benign disease and to examine their relation to hospital procedure volume. METHODS: All patients with a first ERCP in 2005-2008 in Sweden were identified from the Swedish Hospital Discharge Registry. Data on indication, admission method, length of stay (LOS), and comorbid illness were extracted. Patients were linked to the Swedish Death and Cancer Registries. Factors associated with failed index ERCP, early re-admission, and all-cause mortality were identified by multiple logistic analyses. RESULTS: Overall, 12,695 first ERCPs for benign disease were analyzed. The 30-day re-admission rate was 13 % and all-cause 30-day mortality 2.2 %. Failed index ERCP was more common in low-volume than high-volume institutions (p = 0.007). In logistic regression analysis, low hospital procedure volume was an independent predictor of failed index ERCP (odds ratio (OR) 2.72 vs. high), but not 30-day re-admission (p > 0.05). LOS was longer in cases of procedural failure (p < 0.001). All-cause 30-day mortality was independently related to low hospital ERCP volume (OR 1.41 vs. high) and failed ERCP (OR 5.65 vs. successful). CONCLUSION: In this population-based cohort of first ERCPs due to benign disease, lower hospital ERCP volume was related to failed ERCP, which, in turn, was associated with longer LOS. Failed ERCP and lower hospital procedure volume were associated with poor survival, but not with early re-admission following index ERCP. These findings may have implications for service development.
BACKGROUND: Population-based data on hospital procedure volume and outcome of endoscopic retrograde cholangiopancreatography (ERCP) are limited. AIMS: To investigate procedural failure, early re-admission, and all-cause mortality following ERCP performed due to benign disease and to examine their relation to hospital procedure volume. METHODS: All patients with a first ERCP in 2005-2008 in Sweden were identified from the Swedish Hospital Discharge Registry. Data on indication, admission method, length of stay (LOS), and comorbid illness were extracted. Patients were linked to the Swedish Death and Cancer Registries. Factors associated with failed index ERCP, early re-admission, and all-cause mortality were identified by multiple logistic analyses. RESULTS: Overall, 12,695 first ERCPs for benign disease were analyzed. The 30-day re-admission rate was 13 % and all-cause 30-day mortality 2.2 %. Failed index ERCP was more common in low-volume than high-volume institutions (p = 0.007). In logistic regression analysis, low hospital procedure volume was an independent predictor of failed index ERCP (odds ratio (OR) 2.72 vs. high), but not 30-day re-admission (p > 0.05). LOS was longer in cases of procedural failure (p < 0.001). All-cause 30-day mortality was independently related to low hospital ERCP volume (OR 1.41 vs. high) and failed ERCP (OR 5.65 vs. successful). CONCLUSION: In this population-based cohort of first ERCPs due to benign disease, lower hospital ERCP volume was related to failed ERCP, which, in turn, was associated with longer LOS. Failed ERCP and lower hospital procedure volume were associated with poor survival, but not with early re-admission following index ERCP. These findings may have implications for service development.
Authors: Keith Bodger; Katherine Bowering; Sanchoy Sarkar; Elizabeth Thompson; Michael G Pearson Journal: Gastrointest Endosc Date: 2011-08-11 Impact factor: 9.427
Authors: Earl J Williams; Steve Taylor; Peter Fairclough; Adrian Hamlyn; Richard F Logan; Derrick Martin; Stuart A Riley; Peter Veitch; Mark Wilkinson; Paula R Williamson; Martin Lombard Journal: Gut Date: 2006-12-04 Impact factor: 23.059
Authors: Mouen A Khashab; Ali Tariq; Usman Tariq; Katherine Kim; Lucia Ponor; Anne Marie Lennon; Marcia I Canto; Ahmet Gurakar; Qilu Yu; Kerry Dunbar; Susan Hutfless; Anthony N Kalloo; Vikesh K Singh Journal: Clin Gastroenterol Hepatol Date: 2012-04-13 Impact factor: 11.382
Authors: M L Freeman; J A DiSario; D B Nelson; M B Fennerty; J G Lee; D J Bjorkman; C S Overby; J Aas; M E Ryan; G S Bochna; M J Shaw; H W Snady; R V Erickson; J P Moore; J P Roel Journal: Gastrointest Endosc Date: 2001-10 Impact factor: 9.427
Authors: Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali Journal: Med Care Date: 2005-11 Impact factor: 2.983
Authors: Gregory A Coté; Timothy D Imler; Huiping Xu; Evgenia Teal; Dustin D French; Thomas F Imperiale; Marc B Rosenman; Jeffery Wilson; Siu L Hui; Stuart Sherman Journal: Med Care Date: 2013-12 Impact factor: 2.983
Authors: Tae Young Park; Sang Hyeon Choi; Young Joo Yang; Suk Pyo Shin; Chang Seok Bang; Ki Tae Suk; Gwang Ho Baik; Dong Joon Kim Journal: Saudi J Gastroenterol Date: 2017 Sep-Oct Impact factor: 2.485